In treating hematologic malignancies, engineered T-cell therapy outperforms standard transplantation with respect to chronic ...

Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with ...

Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical ...

Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical trial of SENTI-202 maintaining remission - - Strengthened ...

Aptevo Therapeutics (NASDAQ:APVO) announced two additional frontline Acute Myeloid Leukemia (AML) patients have achieved ...

Despite scoring a historic FDA approval last year, Adaptimmune Therapeutics is expressing concerns about its own longevity, cutting preclinical programs and evaluating strategic options. | Despite a ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

FDA granted priority review to Company's BLA for PRGN-2012 for the treatment of adults with recurrent respiratory papillomatosis and set ...

CERo Therapeutics Holdings, Inc., (NASDAQ: CERO) shares were unchanged. The company, an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that ...

TC BioPharm (NASDAQ: TCBP) , a clinical-stage biotechnology company developing allogeneic gamma-delta T cell therapies, is implementing a strategic s ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Tanda leukemia kadang samar dan mungkin mirip dengan gejala penyakit lain. Apa saja gejala leukemia pada anak? Berikut ciri-cirinya.